BioSmart Research, Inc.

BioSmart Research: Invest in the future of cannabinoid therapy.

https://wefunder.com/biosmart.research.inc

Total raised on Wefunder: 53200

Total investors: 21

Quick facts

• Launch in 2019 produced $1.7M in sales
• Biosmart produces pain management and anti-anxiety formulas for clinical and retail distribution
• BioSmart has a 3-year technology lead using high-pressure liquid chromatography for isolate extraction
• BioSmart markets through it's own retail dispensaries, healthcare providers, pharmacies, affiliates, and internet sales
• U.S. Market for non-steroidal OTC pain relievers is $21.9 B/yr. US CBD market is $4.7 B/yr.
• Clinical dosing levels with CBD isolates produce similar results to OTC pain relievers without the side effects.
• BioSmart collaborates with university and clinical researchers and is a member of Choose Wisely, a patient forum
• BioSmart Research represents a responsible approach to improving quality of life and advancing cannabinoid research

Team profiles

• B Renee Searle

Featured investor profiles

• Eric J Exelbert MD